Growth Metrics

Regenerative Medical Technology (RMTG) Current Assets (2017 - 2025)

Historic Current Assets for Regenerative Medical Technology (RMTG) over the last 9 years, with Q3 2025 value amounting to $1.5 million.

  • Regenerative Medical Technology's Current Assets rose 6468.42% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 million, marking a year-over-year increase of 6468.42%. This contributed to the annual value of $1.2 million for FY2024, which is 11708.41% up from last year.
  • Per Regenerative Medical Technology's latest filing, its Current Assets stood at $1.5 million for Q3 2025, which was up 6468.42% from $1.9 million recorded in Q2 2025.
  • In the past 5 years, Regenerative Medical Technology's Current Assets registered a high of $10.8 million during Q3 2021, and its lowest value of $574996.0 during Q4 2023.
  • Over the past 5 years, Regenerative Medical Technology's median Current Assets value was $1.5 million (recorded in 2025), while the average stood at $2.5 million.
  • As far as peak fluctuations go, Regenerative Medical Technology's Current Assets surged by 1734930.57% in 2021, and later plummeted by 8277.52% in 2022.
  • Over the past 5 years, Regenerative Medical Technology's Current Assets (Quarter) stood at $3.0 million in 2021, then crashed by 43.88% to $1.7 million in 2022, then crashed by 66.08% to $574996.0 in 2023, then skyrocketed by 117.08% to $1.2 million in 2024, then rose by 21.01% to $1.5 million in 2025.
  • Its Current Assets stands at $1.5 million for Q3 2025, versus $1.9 million for Q2 2025 and $1.4 million for Q1 2025.